Current Market Information

Last Trade Price (LTP) 810.00 Updated Date 15 October, 2026 Change 0.00 % Open Price 810.00 Day's Range 810.00 - 810.00     Total Trade 0 Total Volume 0 Close Price 810.00 Previous Close Price 810.00 Market Capital in BDT (mn) 1944.000

Contact Information

Designation Name Mobile Number Email Chairman MR. AZIZ MOHAMMAD BHAI MD Mrs. Kazi Tanzzina Ferdous 01912222222 managingdirector@ambeepharma.com CEO Mrs. Kazi Tanzzina Ferdous 01912222222 managingdirector@ambeepharma.com CFO A.K.M Khairul Aziz, 01888814000 khairulaziz.cfo@ambeepharma.com Company Secretary Md. Nasim Uddin 01712045804 cs@ambeepharma.com Office Address 184/1 Tejgaon Industrial Area,G.P.O.Box # 957, Dhaka - 1208 Phone : 88-02- 8870777, 8870788, 8878534 Fax : 88 - 02 - 8870799 Email : info@ambeepharma.com Website : http://www.ambeepharma.com/ Factory Address 184/1 Tejgaon Industrial Area,G.P.O.Box # 957, Dhaka - 1208

Basic Information

Authorized Capital in BDT* (mn) 300.00 Paid-up Capital in BDT* (mn) 24.00 Face Value 10 Paid up Share 2400000     Market Lot 1 Sector PHARMA & CHEMICALS Market Category A

Other Information

Listing Year 1996 Debut Trade Date 06 December, 1995 Type of Instrument     52 Week's Range 742.40 - 825.00 Year End 30 June Reserve / Surplus(mn) 8.33 Remarks Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 30-Sep, 2026 77.25 0 5.54 0 17.21 As on 31-Aug, 2026 77.25 0 5.53 0 17.22 As on 31-Jul, 2026 77.25 0 5.62 0 17.13 As on 30-Jun, 2026 (year ended) 77.25 0 5.83 0 16.92     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company         Half Year End (HY) Information  202512 HY Net Turnover(mn)  77.04 HY Net Profit after tax(mn)  4.46 HY EPS  1.86  AGM Information   AGM Date  18 December, 2025 Record Date  20 November, 2025 Dividend(%)  10.00 (Cash-June 2025) Bonus Issue  20%-2022,20%-2013

   

Interim Financial Performance: 2026
Particulars	Unaudited / Audited
	Q1	Q2	Half Yearly	Q3	9 Months	Annual
	Ending on	Ending on	6 Months	Ending on		Ending on
	30-Sep-2025	31-Dec-2025	31-Dec-2025	31-Mar-2026		30-Jun-2026
Earnings Per Share (EPS)
Basic	0.500	1.360	1.860	0.400	2.260
Diluted*
Earnings Per Share (EPS) - continuing operations
Basic	0.500	1.360	1.860	0.400	2.260
Diluted*
Market price per share at period end

*As per BSEC Directive No. SEC/CMRRCD/2009-193/64, dated September 21, 2010.

*Note: For detail financial statements, please visit company’s website.

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2025	2.21	0	0	0	13.47	0	5.31	0	10%C	0.13
2024	4.03	0	0	0	12.26	0	9.68	0	10%C	0.13
2023	3.79	0	0	0	9.73	0	9.09	0	15%C	0.31
2022	3.36	0	0	0	21.96	0	8.06	0	10%C	0.19
2021	-5.42	0	0	0	18.68	0	-13.01	0		0

Financial Statements
Quarterly Financial Statement	https://www.ambeepharma.com/financial-info
Price Sensitive Information	https://www.ambeepharma.com/financial-info

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To